Doubling Down on a Falling Stock
Buying more shares makes sense when nothing about a company has changed except the price of its stock.
- (opens in new tab)
- (opens in new tab)
- (opens in new tab)
- Newsletter sign up Newsletter
My friend Al just bought more shares of Westport Innovations (symbol WPRT (opens in new tab)), a stock in which he had an 85% loss. His logic? “For just a few thousand dollars, I can cut my cost basis in half.” Al was practicing a technique known as averaging down, in which an investor buys more shares after a price decline on the theory that if you like a stock at, say, $40, you’ll love it at $20.
Westport is working on systems to allow trucks to run on natural gas, but fleet owners have yet to find the economics of its offerings compelling. That’s why over the past three years the stock has plunged from $47 to less than $4. In fact, it has fallen 14% since Al bought his additional shares.
Al was averaging down for the wrong reason. Instead of seeing the drop in Westport’s price as a great opportunity for realizing a loss for tax purposes, he was desperate to get even on his investment—and willing to put even more money at risk to do so. If you average down to avoid copping to an investment mistake, you are compounding your error.

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Legg Mason’s Bill Miller, the onetime star fund manager, famously said that the investor with the “lowest average cost wins.” But if investing were so simple, we’d all be drowning in money. That’s because companies change, and they don’t always meet investors’ expectations.
Consider Dell, a stock that helped make Miller famous. Dell was a monster performer for years, until competitors figured out its strategy and the growth of the personal-computer business slowed. Then Dell became the classic value trap. In July 2005, it traded at nearly $42. A year later, it was $22. Another year later, it was $29. Then $24. Then $13. Finally, on October 29, 2013, founder Michael Dell took the company private at $13.88 per share. You could have averaged down for eight years and lost a truckload of money, only to have Dell step in and decree, “Game over.”
In truth, sometimes averaging down works, and sometimes it doesn’t. It can work if you’re a really good stock picker or, to lower the bar a bit, simply a good conceptual thinker about stocks. Many of the great value investors—such as Warren Buffett and Marty Whitman, who launched the Third Avenue funds—have said that averaging down is a key strategic tool. Buffett hopes a stock will fall after he starts buying so he can buy more at a cheaper price. Whitman knows a stock is likely to go lower after he starts accumulating it because he usually buys when things look bleakest and he believes that the perception of the company won’t change overnight.
When it works. Averaging down makes sense under two circumstances. Do it when a great company has stumbled, but only if you’re pretty sure that the stumble doesn’t reflect a permanent reversal of fortune. Or average down when nothing about a company has changed except its share price.
I just took the latter approach with Adamis Pharmaceuticals (ADMP (opens in new tab)), a tiny firm that is seeking approval for new drug-delivery systems for the allergy- and respiratory-medication markets. I paid $5 a share after learning about Adamis in a newsletter. Once I bought, the stock went down relentlessly for nearly three months, eventually hitting $3.82. I bought more at $3.90 per share and a lot more at $4.10. Now my cost basis is $4.60, and the stock is at $5.60 (as of January 9). Just like that, averaging down has turned a tidy gain into an even bigger profit. What a strategic tool!
Of course, the story is far from over. I don’t know how the investment will ultimately turn out, but I am certain that it made sense to buy more shares after the stock had crumbled 24% from my purchase price. I’m confident because the company’s value hadn’t changed, only its share price.
-
-
In Retirement Planning, What’s Your Retirement Personality?
There are many ways to think about retirement planning, and your personality can influence yours. If your personality and plan match, you have a greater chance of retirement success.
By Samuel V. Gaeta, CFP® • Published
-
Inflation’s Toll: Cuts to Retirement Savings and Health Care
Many consumers struggling to make ends meet amid inflation are reducing retirement planning and health care, both of which can have disastrous results later in life. A professional could help.
By Kristi Martin Rodriguez • Published
-
10 Things You Must Know About Becoming a Millionaire
wealth creation Think you are a millionaire in the making? Read on to see what it takes to be truly destined for wealth.
By the editors of Kiplinger's Personal Finance • Last updated
-
Why This Hedge-Fund Manager Is Shutting Down
investing Now I plan to invest a chunk of the family portfolio in index funds—oh, the horror!
By Andrew Feinberg • Published
-
Know When to Sell a Stock
investing Don't let a stock's stumbles blind you to its long-term potential.
By Andrew Feinberg • Last updated
-
The Secret to Safely Investing in Biotech
investing Seth Klarman was prescient in recognizing that the genomics revolution would supercharge the biotech industry.
By Andrew Feinberg • Last updated
-
Profit from Following Activist Investors
investing When investors like Carl Icahn and Bill Ackman turn the heat on management, shareholders stand to benefit.
By Andrew Feinberg • Published
-
Andrew Feinberg's 6 Stock Picks for 2015
investing Bank of America has made great progress in cutting costs and settling legal claims for shoddy mortgage securities.
By Andrew Feinberg • Last updated
-
Promising Bargains in Biotech Stocks
investing What I like about BioDelivery Sciences is not so much that there are many ways to win as that there are almost no ways to lose.
By Andrew Feinberg • Published
-
Time-Tested Advice for Long-Term Investors
investing Learn from the Kahns, ultra-patient (and successful) value investors who often hold stocks for 20 years.
By Andrew Feinberg • Published